Literature DB >> 9757892

No evidence of the inactivating mutation (C566T) in the follicle-stimulating hormone receptor gene in Brazilian women with premature ovarian failure.

M B da Fonte Kohek1, M C Batista, A J Russell, K Vass, L R Giacaglia, B B Mendonca, A C Latronico.   

Abstract

OBJECTIVE: To investigate the presence of FSH receptor gene mutations in women with premature ovarian failure (POF).
DESIGN: Clinical and molecular studies.
SETTING: Research laboratory in a university setting. PATIENT(S): Fifteen 46,XX women with POF and 42 normal fertile controls. INTERVENTION(S): Exon 7 was amplified and digested with BsmI to screen for the previously described inactivating mutation C566T. Exon 10 was screened for mutations by denaturing gradient gel electrophoresis and direct sequencing. MAIN OUTCOME MEASURE(S): Polymerase chain reaction followed by restriction enzyme analysis, denaturing gradient gel electrophoresis, and direct sequencing. RESULT(S): No inactivating mutations were identified in exons 7 and 10 of the FSH receptor gene in women with familial or sporadic POF. Exon 10 had two polymorphisms, G919A and G2039A, whose allelic frequencies were 46.7% and 56.6%, respectively, in women with POF. The allelic frequency of both polymorphisms was 59.5% in normal fertile controls. CONCLUSION(S): No inactivating mutations in exons 7 and 10 of the FSH receptor gene were identified in Brazilian women with POF. A high frequency of two polymorphisms that are in linkage disequilibrium was found in exon 10 of this gene.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9757892     DOI: 10.1016/s0015-0282(98)00203-9

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  9 in total

1.  FSH receptor gene polymorphisms have a role for different ovarian response to stimulation in patients entering IVF/ICSI-ET programs.

Authors:  Dimitris Loutradis; Eleni Patsoula; Vassilis Minas; Giorgos A Koussidis; Aristeidis Antsaklis; Stylianos Michalas; Antonis Makrigiannakis
Journal:  J Assist Reprod Genet       Date:  2006-05-19       Impact factor: 3.412

2.  Follicle stimulating hormone receptor gene variants in women with primary and secondary amenorrhea.

Authors:  Swati K Achrekar; Deepak N Modi; Pervin K Meherji; Zarine M Patel; Smita D Mahale
Journal:  J Assist Reprod Genet       Date:  2010-03-18       Impact factor: 3.412

3.  Screening of follicle-stimulating hormone receptor gene in women with premature ovarian failure in southern Brazil and associations with phenotype.

Authors:  L C Vilodre; M B F Kohek; P M Spritzer
Journal:  J Endocrinol Invest       Date:  2008-06       Impact factor: 4.256

4.  Impact of follicle-stimulating hormone receptor variants in female infertility.

Authors:  Nermin Seda Ilgaz; Oya Sena Erdogan Aydos; Aynur Karadag; Mehmet Taspinar; Ozlem Gun Eryilmaz; Asuman Sunguroglu
Journal:  J Assist Reprod Genet       Date:  2015-09-24       Impact factor: 3.412

5.  A distribution of two SNPs in exon 10 of the FSHR gene among the women with a diminished ovarian reserve in Ukraine.

Authors:  Ganna Livshyts; Svetlana Podlesnaja; Sergey Kravchenko; Iryna Sudoma; Ludmila Livshits
Journal:  J Assist Reprod Genet       Date:  2008-11-25       Impact factor: 3.412

Review 6.  Genetics of primary ovarian insufficiency: new developments and opportunities.

Authors:  Yingying Qin; Xue Jiao; Joe Leigh Simpson; Zi-Jiang Chen
Journal:  Hum Reprod Update       Date:  2015-08-04       Impact factor: 15.610

Review 7.  Genetics of the ovarian reserve.

Authors:  Emanuele Pelosi; Antonino Forabosco; David Schlessinger
Journal:  Front Genet       Date:  2015-10-15       Impact factor: 4.599

Review 8.  The genetics of premature ovarian failure: current perspectives.

Authors:  Chevy Chapman; Lynsey Cree; Andrew N Shelling
Journal:  Int J Womens Health       Date:  2015-09-23

9.  RANKL is a new Epigenetic Biomarker for the Vasomotor Symptom During Menopause.

Authors:  R Kalkan; M Altarda; O Tosun
Journal:  Balkan J Med Genet       Date:  2020-08-26       Impact factor: 0.519

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.